Top

States Try to Obscure Execution Details as Drugmakers Hinder Lethal Injection

Merck signs $922m deal with Opko Health unit for Epstein-Barr vaccine candidate

After Capping Insulin Copays, Colorado Sets Its Sights on EpiPens

Almond, Soy Drinks Can Be Called Milk, FDA Proposes

GSK and Vir Biotech amend COVID-19 research partnership

Tag: autonomous drug design

Clinical Trials, News, Research and Development

AI Drug Developer Exscientia Closes $525M in Financing

April 28, 2021

Via: Genetic Engineering and Biotechnology News

Artificial intelligence (AI)-based drug developer Exscientia has closed on $525 million in financing, with the proceeds intended for advancing its pipeline through clinical trials, as well as expanding its technology platform toward autonomous drug design. Based in Oxford, U.K., Exscientia […]